Cadence Design Systems reports after the close today with the stock having partially recovered from a brutal month — up 3.8% on Monday to $338.61, but still down more than 10% over the past thirty days.
The rebound is real, but it hasn't closed the distance to where analysts think the stock belongs. The consensus mean target is $396, roughly 17% above current levels — a gap that widened as the stock sold off and analysts largely held their ground. Benchmark initiated with a Buy and a $450 target on July 16. Rosenblatt raised its target to $410 two days earlier. The direction of travel among the covering firms has been uniformly upward through this pullback, which frames the Street's read clearly: the recent weakness is an entry point, not a fundamental deterioration. The bull case rests on Cadence's end-to-end EDA platform, accelerating demand for custom silicon from AI chip developers, and a forward EPS momentum score ranking in the 84th percentile — among the strongest in the software universe. Bears point to valuation that remains stretched even after the selloff, with EV/EBITDA near 28.6 and a P/E around 37, and execution risk tied to recent acquisition-related EPS dilution.
Options positioning is mildly more defensive than usual heading into the event. The put/call ratio has edged up to 1.40, slightly above its 20-day average of 1.34 — a modest lean toward protection, though nowhere near the brief spike to 1.88 seen on July 20. The z-score of 0.43 puts the reading well within one standard deviation of normal, suggesting there is no panic hedging, just a routine tilt ahead of the print. Short interest tells an equally subdued story: at 2.1% of free float and a cost to borrow under 0.40%, there is no meaningful squeeze dynamic in play, and borrow availability is deeply loose with more than 200 million shares available. Short sellers are not pressing a directional view here.
The institutional picture adds one note of genuine interest. Wellington Management added more than 2.3 million shares in its most recently reported period, and JPMorgan Asset Management added over 1.1 million — among the larger disclosed additions in the holder base. Top passive holders BlackRock and State Street are also growing positions incrementally. The insider picture is noisier: a Senior Vice President sold roughly 4,500 shares in multiple tranches on July 22, though the trade significance scores are low and the dollar values are small relative to the float. The pattern looks like routine plan-driven selling, not a signal.
Tonight's print will test whether the revenue and backlog trajectory — the primary metric underpinning the analyst consensus — can justify a stock that has re-rated down by 10% even as EDA demand narratives have stayed intact.
See the live data behind this article on ORTEX.
Open CDNS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
